Strong Start to Fiscal Year 2026
Cardinal Health reported strong double-digit profit growth across all 5 operating segments, indicating robust operating momentum and broad-based performance.
Pharmaceutical and Specialty Solutions Segment
First quarter revenue increased by 23% to $59 billion, driven by Brand and Specialty Pharmaceutical sales growth, with Pharma segment profit increasing by 26% to $667 million.
Increased EPS Guidance
EPS guidance for the full year was raised to a range of $9.65 to $9.85, reflecting 17% to 20% growth from the prior year.
Record Revenue Growth
Total company revenue increased 22% to $64 billion, reflecting growth from all 5 operating segments.
Strong Performance in Other Segments
The 'Other' segment saw a first-quarter revenue increase of 38% to $1.6 billion, with segment profit increasing by 60% to $166 million.
Cash Flow and Shareholder Returns
Generated $1.3 billion in adjusted free cash flow, returned $500 million to shareholders, and ended the quarter with a cash position of $4.6 billion.